Home > Insider Trading > Filing (0000908662-15-000296)

Filing Details

Accession Number:: 0000908662-15-000296
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-08-19 16:14:51
Reporting Period:: 2015-08-17

Filing Date:: 2015-08-19
Accepted Time:: 2015-08-19 16:14:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
907562	Dyax Corp	DYAX	Services-Commercial Physical & Biological Research (8731)	043053198

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1134365	V George Migausky	C/O Dyax Corp. 55 Network Drive Burlington MA 01803-2756	Evp & Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-08-17	65,000	$3.22	136,350	No	4	M	Direct
Common Stock	Acquisiton	2015-08-17	51,000	$10.20	187,350	No	4	M	Direct
Common Stock	Disposition	2015-08-17	64,291	$22.60	123,059	No	4	S	Direct
Common Stock	Disposition	2015-08-17	51,709	$23.17	71,350	No	4	S	Direct
Common Stock	Disposition	2015-08-17	2,306	$22.70	21,694	No	4	S	Indirect	By Trust
Common Stock	Disposition	2015-08-17	694	$23.25	21,000	No	4	S	Indirect	By Trust
Common Stock	Disposition	2015-08-17	2,436	$22.75	18,564	No	4	S	Indirect	By Trust
Common Stock	Disposition	2015-08-17	564	$23.27	18,000	No	4	S	Indirect	By Trust
Common Stock	Disposition	2015-08-17	2,815	$22.82	15,185	No	4	S	Indirect	By Trust
Common Stock	Disposition	2015-08-17	185	$23.38	15,000	No	4	S	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2015-08-17	65,000	$0.00	65,000	$3.22
Common Stock	Stock Option (right to buy)	Disposition	2015-08-17	51,000	$0.00	51,000	$10.20

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
125,000		2020-02-10	No	4	M	Direct
93,000		2024-02-27	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.99, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.46, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $22.15 to $23.10, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4.
Shares are held in trusts, of which Mr. Migausky is the trustee, for the benefit of each of Mr. Migausky's children. Mr. Migausky disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.15 to $23.47, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 6.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $22.16 to $23.15, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 7.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.17 to $23.47, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 8.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $22.29 to $23.27, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 9.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.30 to $23.47, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 10.
The options became fully exercisable on February 10, 2014.
The options become exercisable in 48 substantially equal installments at the end of each monthly anniversary of the date of grant, February 27, 2014.